Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.

[1]  B. Thiers.  Gadolinium-Based Contrast Exposure, Nephrogenic Systemic Fibrosis, and Gadolinium Detection in Tissue , 2009 .

[2]  A. Elster.  Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis , 2009 .

[3]  J. Goulle,et al.  Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis. , 2008, Forensic science international.

[4]  D. Broome,et al.  Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature , 2008, Skeletal Radiology.

[5]  H. Thomsen,et al.  High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent , 2008, Investigative radiology.

[6]  J. Chan,et al.  Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium , 2008, The Australasian journal of dermatology.

[7]  T. Frenzel,et al.  A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast Media , 2008, Investigative radiology.

[8]  J. Dowling,et al.  Nephrogenic systemic fibrosis in a gadolinium‐naive renal transplant recipient , 2008, The Australasian journal of dermatology.

[9]  E. Kanal,et al.  Gadolinium‐induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury , 2007, The British journal of dermatology.

[10]  B. Thiers.  Cutaneous Changes of Nephrogenic Systemic Fibrosis: Predictor of Early Mortality and Association With Gadolinium Exposure , 2008 .

[11]  B. Thiers.  Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned , 2008 .

[12]  A. Elster.  Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort , 2008 .

[13]  R. Stanley.  We Will Miss You, Louisville , 2008 .

[14]  L. Robinson-Bostom,et al.  Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum. , 2008, Journal of the American Academy of Dermatology.

[15]  Diego R. Martín,et al.  Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. , 2008, Radiology.

[16]  C. Chao,et al.  Nephrogenic fibrosing dermopathy in a peritoneal dialysis patient. , 2007, Kidney international.

[17]  R. Woolson,et al.  Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  D. Tudorascu,et al.  Nephrogenic systemic fibrosis: Center case review , 2007, Journal of magnetic resonance imaging : JMRI.

[19]  L. Skov,et al.  Case-control study of gadodiamide-related nephrogenic systemic fibrosis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  E. Simpson,et al.  Gadolinium Is Not the Only Trigger for Nephrogenic Systemic Fibrosis: Insights From Two Cases and Review of the Recent Literature , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  E. Poch,et al.  Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor , 2007, The British journal of dermatology.

[22]  P. Gerke,et al.  Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent. , 2007, Clinical nephrology.

[23]  Amy E. Chadwick,et al.  Nephrogenic Systemic Fibrosis with Multiorgan Involvement in a Teenage Male after Lymphoma, Ewing's Sarcoma, End-Stage Renal Disease, and Hemodialysis , 2007, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[24]  R. Fennell,et al.  Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients , 2007, Pediatric Nephrology.

[25]  Sudhir V. Shah,et al.  Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. , 2007, The New England journal of medicine.

[26]  P. Déchelotte,et al.  Dermopathie néphrogénique fibrosante traitée par photochimiothérapie extracorporelle : rôle du gadolinium ? , 2007 .

[27]  D. Fiorentino,et al.  Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. , 2007, Archives of dermatology.

[28]  D. Chauveau,et al.  [Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: role of gadolinium?]. , 2007, Annales de dermatologie et de venereologie.

[29]  S. Quérin,et al.  La fibrose systémique néphrogénique : nouveau coup dur pour les insuffisants rénaux , 2007 .

[30]  G. Scott,et al.  Nephrogenic systemic fibrosis: a clinicopathologic study of six cases. , 2007, Journal of the American Academy of Dermatology.

[31]  Charu Thakral,et al.  Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. , 2007, Contrast media & molecular imaging.

[32]  H. Y. Lee,et al.  Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature , 2007, Clinical and experimental dermatology.

[33]  V. Werth,et al.  Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature , 2007, International journal of dermatology.

[34]  A. Djamali,et al.  Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.

[35]  S. Cowper,et al.  Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[36]  G. Saab,et al.  Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[37]  V. Runge,et al.  Nephrogenic Systemic Fibrosis: A Review of 6 Cases Temporally Related to Gadodiamide Injection (Omniscan) , 2007, Investigative radiology.

[38]  P. Cheung,et al.  Nephrogenic fibrosing dermopathy: a new clinical entity mimicking scleroderma , 2007, Internal medicine journal.

[39]  J. Zic,et al.  Gadolinium deposition in nephrogenic fibrosing dermopathy. , 2007, Journal of the American Academy of Dermatology.

[40]  S. Cowper,et al.  Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. , 2007, Journal of the American Academy of Dermatology.

[41]  L. Bégin,et al.  [Nephrogenic systemic fibrosis: more hard times for renal failure patients]. , 2007, Nephrologie & therapeutique.

[42]  J. Gerberding,et al.  Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006. , 2007, MMWR. Morbidity and mortality weekly report.

[43]  M. Port,et al.  Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review , 2006, Fundamental & clinical pharmacology.

[44]  R. Nowack,et al.  Scleroderma-like syndrome triggered by gadolinium. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  Lone Skov,et al.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. , 2006, Journal of the American Society of Nephrology : JASN.

[46]  T. Grobner.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  M. Malooa,et al.  Nephrogenic Systemic Fibrosis Among Liver Transplant Recipients : A Single Institution Experience and Topic Update , 2006 .

[48]  S. Jimenez,et al.  Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. , 2004, Arthritis and rheumatism.

[49]  Shawn Cowper,et al.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood. , 2004, The international journal of biochemistry & cell biology.

[50]  P. Flamen,et al.  Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  R. Fennell,et al.  Nephrogenic fibrosing dermopathy in pediatric patients , 2004, Pediatric Nephrology.

[52]  R. Bucala,et al.  Peripheral blood fibrocytes: Mesenchymal precursor cells and the pathogenesis of fibrosis , 2000, Current rheumatology reports.

[53]  P. Leboit,et al.  Scleromyxoedema-like cutaneous diseases in renal-dialysis patients , 2000, The Lancet.